Vaccine and Treatment Evaluation Units
疫苗和治疗评估单位
基本信息
- 批准号:10644709
- 负责人:
- 金额:$ 31.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-12-11 至 2022-11-30
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAddressAdultAntibiotic ResistanceAreaBiological ProductsCategoriesCenters for Disease Control and Prevention (U.S.)ChildhoodClinicalClinical ProtocolsClinical ResearchClinical SciencesClinical TrialsClinical Trials UnitCommunicable DiseasesCommunitiesComplexConsentDatabasesDedicationsDevicesDiagnosticDiagnostic EquipmentDisease OutcomeDrug KineticsEbolaElderlyEmerging Communicable DiseasesEnd Point AssayEnrollmentEnsureEnvironmentEpidemicEthnic OriginEvaluationFacultyFemaleFundingGenerationsGrantHIVHealthcare SystemsHumanImmunologic TestsImmunologicsImmunologyIndividualInfectionInfluenzaInfluenza A virusInfrastructureInstitutesInstitutionInternationalLaboratoriesLaboratory ResearchLeadLeadershipMalariaMentorsMissionModelingNational Institute of Allergy and Infectious DiseaseOutpatientsPaperParticipantPatientsPharmacy facilityPhasePopulation HeterogeneityPositioning AttributePreventionProceduresPrognostic MarkerProtocols documentationPublishingQuality ControlRaceResearchResearch InfrastructureResearch PersonnelResearch TrainingResourcesRiskRouteScienceScientistSexually Transmitted DiseasesSiteSpecimen HandlingStructureSystems BiologyTalentsTherapeuticTrainingTraining and EducationTranslational ResearchTuberculosisUniversitiesVaccinesZIKAantimicrobialbasebiodefensecareer developmentchikungunyaclinical data warehouseclinical research sitedata managementdata qualitydesigndisease diagnosticenteric pathogenflexibilityglobal healthimproved outcomememberneglected tropical diseasesnext generationnovelpandemic diseasepandemic influenzapathogenpredictive markerpregnantpreventprogramsprotocol developmentquality assuranceracial and ethnicracial diversityrecruitrespiratory pathogenresponseretention ratesquare footstudy populationtrial designvaccine evaluationvaccine trialvaccinology
项目摘要
Project Summary/Abstract
The currently NIAID-funded Vaccine and Treatment Evaluation Unit (VTEU) based at Emory University is
ideally positioned to implement the mission of
the Infectious Diseases Clinical Research Consortium (IDCRC)
.
The Emory VTEU is supported by Emory's rich scientific milieu with numerous synergistic grants and various
thematic research centers covering all IDCRC scientific priority areas. The Emory VTEU infrastructure relies on
two clinical research sites with a total of 16,000 square feet of clinical, laboratory, and pharmacy space and 83
faculty members and staff. Over the past decade as a funded VTEU, we have conducted 51 VTEU protocols,
served as lead on 25 trials, performed endpoint assays for 17 studies, and published 22 high impact papers.
We have enrolled ~3,000 participants, 55% are female and 37% from diverse racial and ethnic backgrounds
with a retention rate of ~93%. With its flexible infrastructure, the Emory VTEU demonstrated surge capacity to
contribute to pandemic influenza, Zika, Ebola, and biodefense efforts by prioritizing resources in funds and
staffing. The Emory VTEU will build on the current surge capacity by strengthening our partnership with the
Georgia Clinical and Translational Science Alliance and collaborating with well-established Emory international
partners on a protocol-specific basis. Additionally, to date, our VTEU has trained 28 fellows and junior faculty.
We will build on our significant record of accomplishment and advance the IDCRC mission by implementing
the following specific aims:
1. Engage a broad range of Emory scientists with expertise in established and newly emerging infectious
diseases in the core science of the IDCRC including concept generation and protocol development.
2. Leverage our access to a unique and diverse population and state-of-the-art research infrastructure to
implement all components of the IDCRC science, including study conduct, data quality control and
assurance procedures, data management, and good clinical, laboratory, and pharmacy practices.
3. Optimize our operational flexibility to further enhance our ability to provide surge capacity to address
emerging infectious diseases and pandemic response.
4. Expand our mentoring capacity and enhance career development opportunities for early stage
investigators in the areas of vaccinology, infectious diseases diagnostics, therapeutics, and prevention.
项目总结/摘要
目前由NIAID资助的位于埃默里大学的疫苗和治疗评估单位(VTEU)是
理想地定位于执行以下使命:
传染病临床研究联盟(IDCRC)
.
埃默里大学VTEU由埃默里大学丰富的科学环境支持,有许多协同赠款和各种
涵盖IDCRC所有科学优先领域的专题研究中心。埃默里VTEU基础设施依赖于
两个临床研究中心,共16,000平方英尺的临床,实验室和药房空间和83
教职员工。在过去十年中,作为一个受资助的VTEU,我们已经进行了51个VTEU协议,
担任25项试验的负责人,为17项研究进行终点分析,并发表了22篇高影响力论文。
我们招募了约3,000名参与者,其中55%为女性,37%来自不同种族和民族背景
留存率约为93%。凭借其灵活的基础设施,埃默里VTEU展示了激增能力,
通过优先分配资金资源,为大流行性流感、寨卡病毒、埃博拉病毒和生物防御工作做出贡献,
人员配置。埃默里VTEU将通过加强我们与
格鲁吉亚临床和转化科学联盟,并与著名的埃默里国际合作
在特定协议的基础上。此外,到目前为止,我们的VTEU已经培训了28名研究员和初级教师。
我们将在我们取得的重大成就的基础上,通过实施以下措施来推进IDCRC的使命
具体目标如下:
1.让广泛的埃默里大学科学家参与建立和新出现的传染病
IDCRC核心科学中的疾病,包括概念生成和方案开发。
2.利用我们独特而多样化的人口和最先进的研究基础设施,
实施IDCRC科学的所有组成部分,包括研究实施,数据质量控制和
保证程序、数据管理以及良好临床、实验室和药房规范。
3.优化我们的运营灵活性,以进一步增强我们提供激增能力的能力,
新出现的传染病和大流行病应对措施。
4.扩大我们的辅导能力,并增加早期阶段的职业发展机会
疫苗学、传染病诊断、治疗和预防领域的研究人员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EVAN J ANDERSON其他文献
EVAN J ANDERSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EVAN J ANDERSON', 18)}}的其他基金
Vaccine and Treatment Evaluation Units - DMID 21-0012
疫苗和治疗评估装置 - DMID 21-0012
- 批准号:
10407815 - 财政年份:2021
- 资助金额:
$ 31.61万 - 项目类别:
Emory Vaccine and Treatment Evaluation Unit - DMID 21-0002
埃默里疫苗和治疗评估单位 - DMID 21-0002
- 批准号:
10358957 - 财政年份:2021
- 资助金额:
$ 31.61万 - 项目类别:
Emory Vaccine and Treatment Evaluation Unit - DMID 21-0004
埃默里疫苗和治疗评估单位 - DMID 21-0004
- 批准号:
10401584 - 财政年份:2021
- 资助金额:
$ 31.61万 - 项目类别:
Emory Vaccine and Treatment Evaluation Unit - KidCOVE
埃默里疫苗和治疗评估中心 - KidCOVE
- 批准号:
10382715 - 财政年份:2021
- 资助金额:
$ 31.61万 - 项目类别:
Emory Vaccine and Treatment Evaluation Unit - DMID 20-0034
埃默里疫苗和治疗评估单位 - DMID 20-0034
- 批准号:
10358952 - 财政年份:2021
- 资助金额:
$ 31.61万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 31.61万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 31.61万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 31.61万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 31.61万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 31.61万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 31.61万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 31.61万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 31.61万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 31.61万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 31.61万 - 项目类别:
Research Grant